|
WIPF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.203540E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.196600E-03 |
| Normal-vs-Stage2 |
4.988400E-01 |
| Normal-vs-Stage3 |
2.774600E-01 |
| Normal-vs-Stage4 |
3.946800E-01 |
| Stage1-vs-Stage2 |
5.696600E-01 |
| Stage1-vs-Stage3 |
6.446600E-01 |
| Stage1-vs-Stage4 |
8.599600E-01 |
| Stage2-vs-Stage3 |
8.870000E-01 |
| Stage2-vs-Stage4 |
8.354800E-01 |
| Stage3-vs-Stage4 |
9.082800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.686290E-02 |
| Normal-vs-AfricanAmerican |
2.342200E-02 |
| Normal-vs-Asian |
4.357800E-01 |
| Caucasian-vs-AfricanAmerican |
6.436000E-01 |
| Caucasian-vs-Asian |
9.261000E-01 |
| AfricanAmerican-vs-Asian |
9.417600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.030600E-04 |
| Normal-vs-Female |
4.298400E-01 |
| Male-vs-Female |
1.280490E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.320100E-02 |
| Normal-vs-Extreme_Weight |
1.960780E-04 |
| Normal-vs-Obese |
2.186600E-01 |
| Normal-vs-Extreme_Obese |
3.789000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.771400E-01 |
| Normal_Weight-vs-Obese |
2.834600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.773800E-01 |
| Extreme_Weight-vs-Obese |
4.709600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.029600E-01 |
| Obese-vs-Extreme_Obese |
7.309000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.779400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.673200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.74040000000031E-05 |
| Normal-vs-Age(81-100Yrs) |
7.499100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.783600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.750400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.410040E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.981370E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.706000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.366400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.519400E-03 |
| Normal-VS-Type2 PRCC |
1.347180E-01 |
| Normal-VS-KIRP CIMP |
6.597400E-01 |
| Normal-VS-Unclassified PRCC |
5.577200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.285400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.271400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.617800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.337400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.347240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.694600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.618000E-03 |
| Normal-vs-N1 |
8.168800E-01 |
| Normal-vs-N2 |
2.063800E-01 |
| N0-vs-N1 |
1.099630E-01 |
| N0-vs-N2 |
8.243800E-01 |
| N1-vs-N2 |
5.937200E-01 |
|
|
